Lara Smith-Weber
President chez CONSTELLATION PHARMACEUTICALS, INC.
Postes actifs de Lara Smith-Weber
Sociétés | Poste | Début | Fin |
---|---|---|---|
CONSTELLATION PHARMACEUTICALS, INC. | President | 15/07/2021 | - |
Secrétaire Général | 15/07/2021 | - | |
Treasurer | 15/07/2021 | - |
Historique de carrière de Lara Smith-Weber
Anciens postes connus de Lara Smith-Weber
Sociétés | Poste | Début | Fin |
---|---|---|---|
ONWARD MEDICAL N.V. | Directeur Financier/CFO | - | 01/10/2023 |
MorphoSys US, Inc. | Corporate Officer/Principal | - | - |
MORPHOSYS AG | Comptroller/Controller/Auditor | - | - |
Formation de Lara Smith-Weber
Stanford University | Graduate Degree |
International Institute for Management Development | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 4 |
Allemagne | 2 |
Pays-Bas | 2 |
Opérationnelle
Comptroller/Controller/Auditor | 1 |
President | 1 |
Corporate Secretary | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
MORPHOSYS AG | Health Technology |
ONWARD MEDICAL N.V. | Commercial Services |
Entreprise privées | 2 |
---|---|
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
MorphoSys US, Inc. |
- Bourse
- Insiders
- Lara Smith-Weber
- Expérience